Literature DB >> 19533136

Rich dynamics of a hepatitis B viral infection model with logistic hepatocyte growth.

Sarah Hews1, Steffen Eikenberry, John D Nagy, Yang Kuang.   

Abstract

Chronic hepatitis B virus (HBV) infection is a major cause of human suffering, and a number of mathematical models have examined within-host dynamics of the disease. Most previous HBV infection models have assumed that: (a) hepatocytes regenerate at a constant rate from a source outside the liver; and/or (b) the infection takes place via a mass action process. Assumption (a) contradicts experimental data showing that healthy hepatocytes proliferate at a rate that depends on current liver size relative to some equilibrium mass, while assumption (b) produces a problematic basic reproduction number. Here we replace the constant infusion of healthy hepatocytes with a logistic growth term and the mass action infection term by a standard incidence function; these modifications enrich the dynamics of a well-studied model of HBV pathogenesis. In particular, in addition to disease free and endemic steady states, the system also allows a stable periodic orbit and a steady state at the origin. Since the system is not differentiable at the origin, we use a ratio-dependent transformation to show that there is a region in parameter space where the origin is globally stable. When the basic reproduction number, R (0), is less than 1, the disease free steady state is stable. When R (0) > 1 the system can either converge to the chronic steady state, experience sustained oscillations, or approach the origin. We characterize parameter regions for all three situations, identify a Hopf and a homoclinic bifurcation point, and show how they depend on the basic reproduction number and the intrinsic growth rate of hepatocytes.

Entities:  

Mesh:

Year:  2009        PMID: 19533136     DOI: 10.1007/s00285-009-0278-3

Source DB:  PubMed          Journal:  J Math Biol        ISSN: 0303-6812            Impact factor:   2.259


  24 in total

1.  Global analysis of the Michaelis-Menten-type ratio-dependent predator-prey system.

Authors:  S B Hsu; T W Hwang; Y Kuang
Journal:  J Math Biol       Date:  2001-06       Impact factor: 2.259

Review 2.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

3.  A simple epidemic model with surprising dynamics.

Authors:  Faina Berezovsky; Georgy Karev; Baojun Song; Carlos Castillo-Chavez
Journal:  Math Biosci Eng       Date:  2005-01       Impact factor: 2.080

Review 4.  The woodchuck model of hepatitis B virus infection.

Authors:  B C Tennant; J L Gerin
Journal:  ILAR J       Date:  2001

5.  Molecular epidemiology of hepatitis B virus variants in nonhuman primates.

Authors:  S Grethe; J O Heckel; W Rietschel; F T Hufert
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice.

Authors:  Bo-Kuan Wu; Chao-Chin Li; Huei-Jane Chen; Junn-Liang Chang; King-Song Jeng; Chen-Kung Chou; Ming-Ta Hsu; Ting-Fen Tsai
Journal:  Biochem Biophys Res Commun       Date:  2005-12-27       Impact factor: 3.575

Review 7.  Hepatocyte proliferation in health and in liver failure.

Authors:  Jacek Rozga
Journal:  Med Sci Monit       Date:  2002-02

8.  Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls.

Authors:  J Benn; R J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

9.  The role of cells refractory to productive infection in acute hepatitis B viral dynamics.

Authors:  Stanca M Ciupe; Ruy M Ribeiro; Patrick W Nelson; Geoffrey Dusheiko; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

10.  Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice.

Authors:  Zhongjun Dong; Jianhong Zhang; Rui Sun; Haiming Wei; Zhigang Tian
Journal:  Hepatology       Date:  2007-06       Impact factor: 17.425

View more
  8 in total

1.  New insights into the evolutionary rate of hepatitis B virus at different biological scales.

Authors:  You-Yu Lin; Chieh Liu; Wei-Hung Chien; Li-Ling Wu; Yong Tao; Dafei Wu; Xuemei Lu; Chia-Hung Hsieh; Pei-Jer Chen; Hurng-Yi Wang; Jia-Horng Kao; Ding-Shinn Chen
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

2.  Impact of Population Recruitment on the HIV Epidemics and the Effectiveness of HIV Prevention Interventions.

Authors:  Yuqin Zhao; Daniel T Wood; Hristo V Kojouharov; Yang Kuang; Dobromir T Dimitrov
Journal:  Bull Math Biol       Date:  2016-10-04       Impact factor: 1.758

3.  Modeling the adaptive immune response in HBV infection.

Authors:  Noura Yousfi; Khalid Hattaf; Abdessamad Tridane
Journal:  J Math Biol       Date:  2011-01-14       Impact factor: 2.259

Review 4.  Aerosol Transport Modeling: The Key Link Between Lung Infections of Individuals and Populations.

Authors:  Chantal Darquenne; Azadeh A T Borojeni; Mitchel J Colebank; M Gregory Forest; Balázs G Madas; Merryn Tawhai; Yi Jiang
Journal:  Front Physiol       Date:  2022-06-20       Impact factor: 4.755

5.  Distinct hepatitis B virus dynamics in the immunotolerant and early immunoclearance phases.

Authors:  Hurng-Yi Wang; Ming-Hung Chien; Hsiang-Po Huang; Hsiao-Chi Chang; Chung-Che Wu; Pei-Jer Chen; Mei-Hwei Chang; Ding-Shinn Chen
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

6.  Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection.

Authors:  Sarah Kadelka; Harel Dahari; Stanca M Ciupe
Journal:  Sci Rep       Date:  2021-01-08       Impact factor: 4.379

7.  Analysis and simulation of an Adefovir anti-hepatitis B virus infection therapy immune model with alanine aminotransferase.

Authors:  Yongmei Su; Lei Zhao; Lequan Min
Journal:  IET Syst Biol       Date:  2013-10       Impact factor: 1.615

8.  Modeling and simulating dynamics of complete- and poor-response chronic hepatitis B chinese patients for adefovir and traditional chinese medicine plus adefovir therapy.

Authors:  Lequan Min; Xiao Chen; Yongan Ye; Qun Zhang; Shuying Ru; Xiaoke Li
Journal:  Evid Based Complement Alternat Med       Date:  2013-11-06       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.